CS Genetics is a private discovery tools (healthcare) company. It has raised $16.9 million across 1 recorded round; the latest was a $16.9 million Series A in Sep 2022.
Last price · $/share
—
Implied valuation
—
Total raised
$16.9M
Last round
Later Stage VC (Series A)
Sep 2022
Investors — not yet on record
No investors in CS Genetics are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of CS Genetics with a free Private Market View account
·Watch CS Genetics: the Monday email on marks, rounds and moves
